EP3122900A1 - Cancer treatment with c-met antagonists and correlation of the latter with hgf expression - Google Patents

Cancer treatment with c-met antagonists and correlation of the latter with hgf expression

Info

Publication number
EP3122900A1
EP3122900A1 EP15716253.8A EP15716253A EP3122900A1 EP 3122900 A1 EP3122900 A1 EP 3122900A1 EP 15716253 A EP15716253 A EP 15716253A EP 3122900 A1 EP3122900 A1 EP 3122900A1
Authority
EP
European Patent Office
Prior art keywords
hgf
patient
method
embodiments
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP15716253.8A
Other languages
German (de)
French (fr)
Inventor
Wei Yu
David SHAMES
Hartmut Koeppen
See PHAN
Sandra ROST
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann-La Roche AG
Original Assignee
F Hoffmann-La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US201461969706P priority Critical
Priority to US201461985316P priority
Application filed by F Hoffmann-La Roche AG filed Critical F Hoffmann-La Roche AG
Priority to PCT/US2015/022282 priority patent/WO2015148531A1/en
Publication of EP3122900A1 publication Critical patent/EP3122900A1/en
Application status is Pending legal-status Critical

Links